Distinguished in WT1-Related Wilms Tumor Syndromes

Dr. Zin W. Myint

Oncology | Hematology Oncology
UK Healthcare
Kentucky Medical Services Foundation, Inc
800 Rose St, 
Lexington, KY 
Offers Telehealth

Distinguished in WT1-Related Wilms Tumor Syndromes
UK Healthcare
Kentucky Medical Services Foundation, Inc
800 Rose St, 
Lexington, KY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Zin Myint is an Oncologist and a Hematologist Oncology provider in Lexington, Kentucky. Dr. Myint is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Muscle Invasive Bladder Cancer, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Orchiectomy, and Nephrectomy.

Her clinical research consists of co-authoring 64 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Hematology Oncology
Licenses
Internal Medicine in KY
Hospital Affiliations
Baptist Health Lexington
University Of Kentucky Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

KENTUCKY MEDICAL SERVICES FOUNDATION, INC
800 Rose St, Lexington, KY 40536
Call: 859-323-5000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

A Single Arm Phase II Study of Bone-Targeted Sn-117m-DTPA in Symptomatic Castration Resistant Prostate Cancer With Skeletal Metastases
A Single Arm Phase II Study of Bone-Targeted Sn-117m-DTPA in Symptomatic Castration Resistant Prostate Cancer With Skeletal Metastases
Enrollment Status: Terminated
Publish Date: October 03, 2025
Intervention Type: Other, Radiation
Study Phase: Phase 2
A Pilot Study of Tazemetostat and Pembrolizumab (MK-3475) in Advanced Urothelial Carcinoma
A Pilot Study of Tazemetostat and Pembrolizumab (MK-3475) in Advanced Urothelial Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: September 03, 2025
Intervention Type: Procedure, Drug, Biological
Study Drugs: Pembrolizumab, Tazemetostat
Study Phase: Phase 1/Phase 2
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 27, 2025
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

62 Total Publications

Geographical Differences in the Management and Outcomes of Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab After Progression on Platinum-Based Chemotherapy: Results From ARON-2 Study.
Geographical Differences in the Management and Outcomes of Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab After Progression on Platinum-Based Chemotherapy: Results From ARON-2 Study.
Journal: JCO global oncology
Published: July 08, 2025
View All 62 Publications
Similar Doctors
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Amy M. Schell
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Amy M. Schell
Hematology Oncology | Hematology | Oncology

Baptist Health Medical Group Inc

1700 Nicholasville Rd, 
Lexington, KY 
 (0.8 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Amy Schell is a Hematologist Oncology specialist and a Hematologist in Lexington, Kentucky. Dr. Schell is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Breast Cancer. Dr. Schell is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Arvinda Padmanabhan
Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Arvinda Padmanabhan
Oncology

Baptist Health Medical Group Inc

801 Eastern Bypass, 
Richmond, KY 
 (23.9 miles away)
859-623-3131
Languages Spoken:
English
See accepted insurances

Arvinda Padmanabhan is an Oncologist in Richmond, Kentucky. Dr. Padmanabhan is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Familial Colorectal Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Astrocytoma.

Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Lee G. Hicks
Hematology Oncology | Oncology
Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Lee G. Hicks
Hematology Oncology | Oncology

Baptist Health Medical Group Inc

1700 Nicholasville Rd, 
Lexington, KY 
 (0.8 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lee Hicks is a Hematologist Oncology specialist and an Oncologist in Lexington, Kentucky. Dr. Hicks is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Essential Thrombocythemia, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Monoclonal Gammopathy of Undetermined Significance (MGUS). Dr. Hicks is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Myint's expertise for a condition
ConditionClose
    • Distinguished
    • Chromophobe Renal Cell Carcinoma
      Dr. Myint is
      Distinguished
      . Learn about Chromophobe Renal Cell Carcinoma.
      See more Chromophobe Renal Cell Carcinoma experts
    • Muscle Invasive Bladder Cancer
      Dr. Myint is
      Distinguished
      . Learn about Muscle Invasive Bladder Cancer.
      See more Muscle Invasive Bladder Cancer experts
    • Renal Cell Carcinoma (RCC)
      Dr. Myint is
      Distinguished
      . Learn about Renal Cell Carcinoma (RCC).
      See more Renal Cell Carcinoma (RCC) experts
    • WT1-Related Wilms Tumor Syndromes
      Dr. Myint is
      Distinguished
      . Learn about WT1-Related Wilms Tumor Syndromes.
      See more WT1-Related Wilms Tumor Syndromes experts
    • Advanced
    • Adult Soft Tissue Sarcoma
      Dr. Myint is
      Advanced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Bladder Cancer
      Dr. Myint is
      Advanced
      . Learn about Bladder Cancer.
      See more Bladder Cancer experts
    • Clear Cell Sarcoma
      Dr. Myint is
      Advanced
      . Learn about Clear Cell Sarcoma.
      See more Clear Cell Sarcoma experts
    • Familial Benign Copper Deficiency
      Dr. Myint is
      Advanced
      . Learn about Familial Benign Copper Deficiency.
      See more Familial Benign Copper Deficiency experts
    • Familial Wilms Tumor 2
      Dr. Myint is
      Advanced
      . Learn about Familial Wilms Tumor 2.
      See more Familial Wilms Tumor 2 experts
    • Prostate Cancer
      Dr. Myint is
      Advanced
      . Learn about Prostate Cancer.
      See more Prostate Cancer experts
    View All 8 Advanced Conditions
    • Experienced
    • Anal Cancer
      Dr. Myint is
      Experienced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Anemia
      Dr. Myint is
      Experienced
      . Learn about Anemia.
      See more Anemia experts
    • Bone Tumor
      Dr. Myint is
      Experienced
      . Learn about Bone Tumor.
      See more Bone Tumor experts
    • Choriocarcinoma
      Dr. Myint is
      Experienced
      . Learn about Choriocarcinoma.
      See more Choriocarcinoma experts
    • Classical Hodgkin Lymphoma
      Dr. Myint is
      Experienced
      . Learn about Classical Hodgkin Lymphoma.
      See more Classical Hodgkin Lymphoma experts
    • Familial Prostate Cancer
      Dr. Myint is
      Experienced
      . Learn about Familial Prostate Cancer.
      See more Familial Prostate Cancer experts
    View All 24 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved